Semi-Annual Consolidated Balance Sheet

BrightPath Biotherapeutics Co., Ltd. - Filing #7356865

Concept As at
2023-12-31
As at
2023-03-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,296,943,000 JPY
1,530,969,000 JPY
Other
82,307,000 JPY
120,184,000 JPY
Current assets
1,379,275,000 JPY
1,651,210,000 JPY
Non-current assets
Property, plant and equipment
0 JPY
0 JPY
Property, plant and equipment
Intangible assets
Intangible assets
0 JPY
0 JPY
Investments and other assets
49,296,000 JPY
50,234,000 JPY
Investments and other assets
Non-current assets
49,296,000 JPY
50,234,000 JPY
Assets
1,428,572,000 JPY
1,701,444,000 JPY
Liabilities
Current liabilities
Income taxes payable
5,976,000 JPY
10,409,000 JPY
Other
91,907,000 JPY
66,072,000 JPY
Current liabilities
597,902,000 JPY
76,558,000 JPY
Non-current liabilities
Asset retirement obligations
22,625,000 JPY
22,556,000 JPY
Other
0 JPY
0 JPY
Non-current liabilities
57,916,000 JPY
57,345,000 JPY
Liabilities
655,819,000 JPY
133,903,000 JPY
Net assets
Shareholders' equity
Share capital
439,412,000 JPY
362,185,000 JPY
Capital surplus
2,747,947,000 JPY
2,670,720,000 JPY
Retained earnings
-2,439,399,000 JPY
-1,485,633,000 JPY
Treasury shares
0 JPY
0 JPY
Shareholders' equity
747,960,000 JPY
1,547,272,000 JPY
Share acquisition rights
24,792,000 JPY
20,268,000 JPY
Net assets
772,753,000 JPY
1,567,541,000 JPY
Liabilities and net assets
1,428,572,000 JPY
1,701,444,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.